ImmunityBio Inc (NASDAQ:IBRX)’s traded shares stood at 6.75 million during the last session, with the company’s beta value hitting 0.02. At the close of trading,
In the latest trading session,, 1.22 million ImmunityBio Inc (NASDAQ:IBRX) shares changed hands as the company’s beta touched -0.01. With the company’s most recent per
ImmunityBio Inc (NASDAQ:IBRX) has a beta value of -0.01 and has seen 2.44 million shares traded in the recent trading session. The company, currently valued
In the last trading session, 7.12 million shares of the ImmunityBio Inc (NASDAQ:IBRX) were traded, and its beta was -0.01. Most recently the company’s share
ImmunityBio Inc (NASDAQ:IBRX)’s traded shares stood at 8.65 million during the last session, with the company’s beta value hitting 0.01. At the close of trading,
In the latest trading session,, 5.78 million ImmunityBio Inc (NASDAQ:IBRX) shares changed hands as the company’s beta touched -0.01. With the company’s most recent per
ImmunityBio Inc (NASDAQ:IBRX) has a beta value of -0.01 and has seen 8.37 million shares traded in the last trading session. The company, currently valued
During the last session, ImmunityBio Inc (NASDAQ:IBRX)’s traded shares were 6.43 million, with the beta value of the company hitting -0.00. At the end of
In the last trading session, 6.25 million shares of the ImmunityBio Inc (NASDAQ:IBRX) were traded, and its beta was 0.03. Most recently the company’s share
ImmunityBio Inc (NASDAQ:IBRX)’s traded shares stood at 9.67 million during the last session, with the company’s beta value hitting 0.07. At the close of trading,
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne